Topic: Weight Loss

2 chapters across the catalog

96: Out of Luck
50:24 - 54:45

96: Out of Luck

Ozempic Weight Loss Trend and Off-Label Use

Ozempic, a diabetes medication containing semaglutide, has become a viral weight-loss sensation on TikTok and in Hollywood. Manufacturer Novo Nordisk maintains that the drug is not intended for off-label weight loss, though the FDA allows doctors to prescribe it as they see fit. The hosts note that while the drug is marketed heavily to white women in media, black communities are also being targeted using cultural terms like "sugar" for diabetes.

96: Out of Luck
1:37:00 - 1:39:58

96: Out of Luck

Qnexa and the Search for the Holy Grail Diet Pill

The discussion covers Qnexa, a diet drug that combined a seizure medication with Phentermine (half of the original Fen-Phen). While marketed as a "holy grail" for obesity, medical experts cautioned that drugs cannot replace diet and exercise. The hosts use this as a final example of the cyclical nature of "magic" weight-loss solutions and their inevitable side effects.